Updated:
Biovance Capital
Biovance Capital is a biotech-focused fund investing in disruptive, early-stage biopharma companies across Europe. It invests in seed and Series A rounds and...
Biovance Capital
Biovance Capital is a biotech-focused fund investing in disruptive, early-stage biopharma companies across Europe. It invests in seed and Series A rounds and works closely with entrepreneurs to build leading companies with transformative treatments for patients. The fund is backed by the European Investment Fund and other public and private investors.
General information
Firm type
Private Equity
Year founded
2023
Location
Region
Europe
Country
Portugal
City
Lisbon
Corporate office
Lisbon, Portugal
Principals
João Incio
MD, PhD, General Partner
Ricardo Perdigão Henriques
PhD, Managing Partner
André Albergaria
PhD, Principal
Sector focus
Frequently asked questions
What stages does Biovance Capital target?
Records list early-stage seed, start-up, expansion, late-stage growth and general venture.
Where is Biovance Capital headquartered?
The firm is based in Lisbon, Portugal.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: